Seroconversion for cytomegalovirus infection in a cohort of pregnant women in Québec, 2010–2013

Fiche du document

Date

5 novembre 2018

Type de document
Périmètre
Langue
Identifiants
Licences

Ce document est mis à disposition selon les termes de la Licence Creative Commons Paternité 4.0 International. / This work is licensed under a Creative Commons Attribution 4.0 International License. , http://creativecommons.org/licenses/by/4.0/


Mots-clés

Cytomegalovirus Infectious disease epidemiology Pregnancy Prevention Serology

Sujets proches En

Infectious diseases

Citer ce document

V. Lamarre et al., « Seroconversion for cytomegalovirus infection in a cohort of pregnant women in Québec, 2010–2013 », Papyrus : le dépôt institutionnel de l'Université de Montréal, ID : 10.1017/S0950268815003167


Métriques


Partage / Export

Résumé 0

Cytomegalovirus (CMV) is the leading cause of congenital infection and non-genetic sensorineural hearing loss in children. There are no recent data on the incidence of CMV infection during pregnancy in Canada. This present study was undertaken to determine the seroprevalence of CMV IgG antibodies and the rate of seroconversion in a cohort of pregnant women in the province of Québec, Canada. We used serum samples and questionnaire data collected as part of the 3D Pregnancy and Birth Cohort Study (2010–2013) conducted in Québec, Canada. CMV IgG antibodies were determined in serum samples collected at the first and third trimesters. Associations between independent variables and seroprevalence were assessed using logistic regression, and associations with seroconversions, by Poisson regression. Of 1938 pregnant women tested, 40·4% were seropositive for CMV at baseline. Previous CMV infection was associated with: working as a daycare educator, lower education, lower income, having had children, first language other than French or English, and being born outside Canada or the United States. Of the 1122 initially seronegative women, 24 (2·1%) seroconverted between their first and third trimesters. The seroconversion rate was 1·4 [95% confidence interval (CI) 0·9–2·1]/ 10 000 person-days at risk or 3·9 (95% CI 2·5–5·9)/100 pregnancies (assuming a 280-day gestation). The high proportion of pregnant women susceptible to CMV infection (nearly 60%) and the subsequent rate of seroconversion are of concern.

document thumbnail

Par les mêmes auteurs

Sur les mêmes sujets

Exporter en